Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Xu, Y. Zhang, L. O. Cardell (Stockholm, Sweden). The effect of nicotine on COX-dependent airway relaxation and inflammatory mediator expression. Eur Respir J 2010; 36: Suppl. 54, 4285

Member's Comments

No comment yet.

Related content which might interest you: Remicade suppresses cytokine-induced up-regulation of bradykinin receptor-mediated airway smooth muscle contractions Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions Year: 2005 The effect of endocannabinoid metabolism inhibition on airway inflammation in mice Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 The role of ACN9 in the inflammatory response in the airway Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Concomitant exposure to nicotine and endotoxin in vitro induces murine airway hyperreactivity possibly via nicotine-induced upregulation of toll-like receptors Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Anti-inflammatory effect of bosentan on endothelin-1- and TNF-α-induced GMCSF expression in human airways smooth muscle cells – role of MAPkinases ERK-1,-2 Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007 Effect of cigarette smoke extract on Th17 inflammation and the anti-inflammatory effect of glucocorticoids in human airway smooth muscle cells Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression Source: Eur Respir J 2003; 22: 290-297 Year: 2003 Responses of bronchial smooth muscle to inflammation and disease Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease Year: 2005 Quercetin attenuates inflammation in cigarette smoke stimulated airway epithelial cells: Possible involvement of autophagy Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Cigarette smoke-induced activation of the integrated stress response in COPD airway epithelial cells and the role of oxidative stress Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Budesonide reverses IL-13–induced airway hyper-responsiveness but has little effect on β2 agonist response in human small airways Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Effect of TGF-β on Nrf2 activity in airway smooth muscle cells; role in antioxidant and inflammatory responses Source: Annual Congress 2010 - Airway smooth muscle cells Year: 2010 Effect of cigarette smoke extract on inflammatory cytokine and chemokine production in human airway smooth muscle cells Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 Role of airway smooth muscles in chronic airway inflammation and lung fibrosis and possible therapeutic potential of endothelin receptor antagonism Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Platelets induce airway smooth muscle cell proliferation through mechanisms dependent on ROS and 5-LOX metabolites Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005